ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning
Author:
Affiliation:
1. Department of Medicine; Mayo Clinic; Rochester Minnesota
2. Division of Hematology; Mayo Clinic; Rochester Minnesota
3. Division of Transfusion Medicine; Mayo Clinic; Rochester Minnesota
Publisher
Wiley
Subject
Hematology,Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.13353/fullpdf
Reference34 articles.
1. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases;Slavin;Blood,1998
2. Transfusions after nonmyeloablative or reduced-intensity conditioning regimens;Baron;Leukemia,2006
3. The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation;Wang;Br J Haematol,2010
4. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning;Worel;Transfusion,2002
5. ABO mismatch is associated with increased non-relapse mortality after allogeneic hematopoietic cell transplantation;Logan;Biol Blood Marrow Transplant,2015
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The impact of infused red blood cell volume on major and bidirectional ABO-mismatched bone marrow transplantation;Cytotherapy;2024-05
2. ABO incompatibility does not affect transfusion requirements or clinical outcomes of unrelated cord blood transplantation after myeloablative conditioning for haematological malignancies;BLOOD TRANSFUS-ITALY;2022
3. ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes;Transplantation Direct;2021-07-09
4. Investigation of risk factors associated with erythrocyte engraftment after ABO‐incompatible hematopoietic stem cell transplantation;Clinical Transplantation;2021-05-12
5. Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide;Blood Advances;2021-03-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3